Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide: Chelmsford, Massachusetts Thursday, July 3, 202 ...

A rise in the number of B6 toxicity cases across the nation has sparked action by the TGA to move products behind pharmacy counters.

Cancer survivors often experience persistent physical symptoms long after treatment ends. Expert advice highlights holistic ...

The Global Neuropathic Pain Market is valued approximately at USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.73% over the forecast period 2024-2032.

Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Treatment Market 2025-2029" has been added to ResearchAndMarkets.com's offering. Powered by Money.com - Yahoo may earn ...

SPONSORED — For the millions suffering from peripheral neuropathy, a painful and progressive nerve condition, a new approach may offer lasting relief without the need for lifelong medication. Dr ...

Study objective: Although lipid lowering drugs are effective in preventing morbidity and mortality from cardiovascular events, the extent of their adverse effects is not clear. This study explored the ...

Many with peripheral neuropathy use medications like Gabapentin, Lyrica, or Cymbalta for relief, but these only mask symptoms instead of treating the cause. While they may temporarily reduce pain ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of ...

HHS Secretary Robert F. Kennedy Jr. tells 'Hannity' about the importance of transparency in the food industry. New Promise Neuropathy talks treating Peripheral Neuropathy ...

This post is sponsored content. TYLER, Texas (KETK) – Sarah Brezina with New Promise Neuropathy stopped by East Texas Live on Thursday to talk about treating Peripheral Neuropathy. For more ...